Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain

Condition:   Moderate to Severe Acute Lower Back Pain Interventions:   Drug: SP-103;   Drug: Placebo Sponsors:   Scilex Pharmaceuticals, Inc.;   Worldwide Clinical Trials Not yet recruiting

Source: ClinicalTrials.gov - October 27, 2021 Category: Research Source Type: clinical trials